Effects of SLC22A2 808G>T polymorphism and bosutinib concentrations on serum creatinine in patients with chronic myeloid leukemia receiving bosutinib therapy
Abstract The purpose of this study was to investigate the effects of SLC22A2 808G>T polymorphism and trough concentrations (C0) of bosutinib on serum creatinine in 28 patients taking bosutinib. At 1, 3, 6, 12, 24, and 36 months after administration, analysis of bosutinib C0 and creatinine was per...
Enregistré dans:
Auteurs principaux: | Maiko Abumiya, Naoto Takahashi, Saori Takahashi, Tomoko Yoshioka, Yoshihiro Kameoka, Masatomo Miura |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/cddf7025ea95456eac4b8a2a0965cf7f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Structural and spectroscopic analysis of the kinase inhibitor bosutinib and an isomer of bosutinib binding to the Abl tyrosine kinase domain.
par: Nicholas M Levinson, et autres
Publié: (2012) -
Bosutinib in the management of chronic myelogenous leukemia
par: Keller-von Amsberg G, et autres
Publié: (2013) -
Comparing Therapeutic Focused Ultrasound (tfUS) in Conjunction with Bosutinib versus Independent tfUS Administration Among Alzheimer’s Patients
par: Margaret Zielinski, et autres
Publié: (2021) -
Acta Nº808
par: Banco Central de Chile
Publié: (2019) -
Low creatinine levels in diabetes mellitus among older individuals: the Yuport Medical Checkup Center Study
par: Saori Kashima, et autres
Publié: (2021)